Precision BioSciences Inc expected to post a loss of 17 cents a share - Earnings Preview

Precision Biosciences

03/11/2023 14:48

* Precision BioSciences Inc  DTIL.OQ   DTIL.O  is expected
to show
a rise in quarterly revenue when it reports  results 
    * The Durham North Carolina-based  company is expected to
report 
a 16.9% increase in revenue to $8.605 million from $7.36 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Precision
BioSciences Inc
is for a loss of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Precision
BioSciences Inc is $3​, above​ its last closing price of $0.40.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.25       -0.24      -0.10     Beat    59
 Mar. 31 2023  -0.23       -0.23      -0.23     Met     -1.8
 Dec. 31 2022  -0.22       -0.21      -0.26     Missed  -25.3​
 Sep. 30 2022  -0.25       -0.26      -0.22     Beat    17
 ​​Jun.        -0.41       -0.41      -0.46     Missed  -11.9
 30 2022                                                
 Mar. 31 2022  -0.53       -0.54      -0.46     Beat    15​
 Dec. 31 2021  -0.58       -0.47      -0.52     Missed  -9.9
 Sep. 30 2021  -0.62       -0.59      -0.19     Beat    67.9
 This summary was machine generated November 3 at 14:48 GMT.  All
figures in US dollars  unless otherwise stated